Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Irish Examiner
12m
EU regulator backs use of Novo's Wegovy for obesity-related heart condition
The agency has also backed use of Wegovy to lower major heart risks and strokes in overweight or obese adults without ...
25m
on MSN
Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure
Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
Cancels appearance w/ Duda
Boy kills bear, saves father
30 yrs in prison for assault
To get a second moon
Ban called for in TX schools
Vows to remain in race
Families lose appeal
Collapse hazard recall
Brazil threatens daily fines
COVID, Wuhan market link
Dow, S&P hit record highs
Overdose deaths drop in US
Man charged for threats
Rally attendees injured
UN backs Palestine
Joins Motion Picture Assn.
Los Angeles dengue cases
NYC subway joyride arrest
Deal to build new arena
FTC on privacy controls
Existing home sales drop
Gun case sentencing delay
160M euros to Ukraine
EU warns Apple
US healthcare system falls
Hails economic progress
To receive Holbrooke award
AC mayor, wife indicted
Retaliated against scientists
Retires after 17 seasons
Related topics
Ozempic
Novo Nordisk
Hims
Amycretin
Liraglutide
Feedback